Loading...
•
Sep 30, 2023
Select Medical Q3 2023 Earnings Report
Select Medical's financial performance improved with revenue and net income increasing compared to the same quarter last year.
Key Takeaways
Select Medical Holdings Corporation reported a 6.2% increase in revenue to $1,665.7 million for the third quarter ended September 30, 2023, compared to $1,567.8 million for the same quarter, prior year. Net income increased 59.5% to $60.8 million. Earnings per common share increased 75.8% to $0.38, and adjusted earnings per common share increased 113.7% to $0.46.
Revenue increased by 6.2% to $1,665.7 million compared to the same quarter last year.
Net income increased by 59.5% to $60.8 million compared to the same quarter last year.
Earnings per common share increased by 75.8% to $0.38 compared to the same quarter last year.
Adjusted earnings per common share increased by 113.7% to $0.46 compared to the same quarter last year.
Select Medical
Select Medical
Select Medical Revenue by Segment
Revenue by Segment
Critical Illness Recovery Hospital Revenue
CapyFin.comRehabilitation Hospital Revenue
CapyFin.comOutpatient Rehabilitation Revenue
CapyFin.com Forward Guidance
Select Medical is maintaining its business outlook for 2023 with expected revenue to be in the range of $6.55 billion to $6.7 billion, expected Adjusted EBITDA in the range of $795.0 million to $825.0 million, and fully diluted earnings per share to be in the range of $1.77 to $1.94. Select Medical expects adjusted earnings per share, which was revised to exclude the actual tax-effected loss on early retirement of debt, to be in the range of $1.85 to $2.02.
Revenue & Expenses
Visualization of income flow from segment revenue to net income